Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives

Trimble, John O; Light, Bob

Abstract

Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives

Author(s): Trimble John O, Light Bob

Issue: Nov/Dec 2017 - Volume 21, Number 6

View All Articles in Issue

Page(s): 530-535

Download in electronic PDF format for $75

Abstract

Transdermal compositions for hormone replacement are comprised of exogenous hormones that are biochemically similar to those produced endogenously by the ovaries or elsewhere in the body. In this work, estradiol, estriol, and testosterone were loaded in transdermal vehicles, prepared using one of three selected penetration enhancer mixtures: Vehicle 1 (olive oil and oleic acid), Vehicle 2 (isopropyl palmitate and lecithin), and Vehicle 3 (isopropyl myristate and lecithin). The influence of penetration enhancers on transdermal delivery was evaluated using Franz-type diffusion cells and Normal Human 3D Model of Epidermal Tissue. Results showed that drug delivery is affected by the penetration enhancer used in the transdermal composition.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2017 Pg. 530-535	Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Author(s): Trimble John O, Light Bob
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
Jan/Feb 2001 Pg. 52-54	Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Author(s): Ford Gina, Garcia Lea
Nov/Dec 2016 Pg. 447-454	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Author(s): Deleruyelle Laura J
Sep/Oct 2016 Pg. 359-364	Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Author(s): Deleruyelle Laura J
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
Jan/Feb 2003 Pg. 48-50	Featured Excipient: Flavor Enhancing Agents Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 6-16	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3 Author(s): Deleruyelle Laura J
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Jul/Aug 2003 Pg. 250-256	A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Author(s): Gillson George R, Zava David T
Jan/Feb 2015 Pg. 6-12	Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Mar/Apr 2012 Pg. 110-114	Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Author(s): Griffee Chris, Delano Amy
Sep/Oct 2009 Pg. 392-399	Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing Author(s): Kells John, Dollbaum Charles M
Mar/Apr 2002 Pg. 142-146	Bioidentical Hormone Replacement Therapy, Part 3, A Review of Author(s): Wepfer Scott T
May/Jun 2018 Pg. 190-195	Establishing a Rationale for Compounding Hormone Replacement Therapy Author(s): Biundo Bruce
Jan/Feb 2024 Pg. 22-27	Establishing a Rationale for Compounding Hormone Replacement Therapy Author(s): Biundo Bruce
Sep/Oct 2013 Pg. 370-374	Chemical Penetration Enhancers Author(s): Newton Stephen J
Mar/Apr 2015 Pg. 152-160	Transdermal Delivery of Nisoldipine: Refinement of Vehicles Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Jan/Feb 2002 Pg. 50-54	Bioidentical Hormone Replacement Therapy, Part 2, A Review of Author(s): Wepfer Scott T